Science
Mechanism of Action
This derivative inhibits key inflammatory mediators such as cytokines and COX-2, primarily by interfering with the NF-κB pathway. Its enhanced lipophilicity supports improved cellular uptake compared to its parent compound, curcumin.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In a murine model, 60-120 mg/kg (oral) significantly inhibited inflammation more effectively than curcumin in chronic stages.
- 02 In vitro, 200 µg/mL reduced multispecies subgingival biofilm metabolic activity by 51%.
- 03 In vitro, it demonstrated potent bacterial inhibition against Enterococcus faecalis biofilm at 15.6-31.25 µg/mL.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Acetylation enhances lipophilicity and is expected to improve hydrolytic stability compared to curcumin, which is less stable at alkaline pH.
Safety
Safety Profile
Diacetylcurcumin has not been reviewed by CIR. Its parent compound, curcumin, is recognized by FDA but was delisted for food use, and SCCS has not assessed its cosmetic safety.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Diacetylcurcumin offers promising anti-inflammatory and antimicrobial benefits with improved stability, though further topical human efficacy and safety data are needed.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources